Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer
CCO Oncology Podcast - Un podcast de Clinical Care Options
Catégories:
Listen as experts discuss key clinical pearls and answer frequently asked questions on the use of CDK4/6 inhibitors for HR-positive/HER2-negative early and metastatic breast cancer in this podcast episode, including insights related to optimal sequencing and ensuring adherence to therapy.
